Centro de Biotecnologia, Instituto Butantan, São Paulo, SP, Brasil.
Braz J Med Biol Res. 2011 Apr;44(4):297-302. doi: 10.1590/s0100-879x2011007500025. Epub 2011 Mar 4.
Leptospirosis is a reemerging infectious disease and the most disseminated zoonosis worldwide. A leptospiral surface protein, LipL32, only occurs in pathogenic Leptospira, and is the most abundant protein on the bacterial surface, being described as an important factor in host immunogenic response and also in bacterial infection. We describe here an alternative and simple purification protocol for non-tagged recombinant LipL32. The recombinant LipL32(21-272) was expressed in Escherichia coli without His-tag or any other tag used to facilitate recombinant protein purification. The recombinant protein was expressed in the soluble form, and the purification was based on ion exchange (anionic and cationic) and hydrophobic interactions. The final purification yielded 3 mg soluble LipL32(21-272) per liter of the induced culture. Antiserum produced against the recombinant protein was effective to detect native LipL32 from cell extracts of several Leptospira serovars. The purified recombinant LipL32(21-272) produced by this protocol can be used for structural, biochemical and functional studies and avoids the risk of possible interactions and interferences of the tags commonly used as well as the time consuming and almost always inefficient methods to cleave these tags when a tag-free LipL32 is needed. Non-tagged LipL32 may represent an alternative antigen for biochemical studies, for serodiagnosis and for the development of a vaccine against leptospirosis.
钩端螺旋体病是一种重新出现的传染病,也是世界上分布最广的动物传染病。一种钩端螺旋体表面蛋白 LipL32 仅存在于致病性钩端螺旋体中,是细菌表面最丰富的蛋白,被描述为宿主免疫应答和细菌感染的重要因素。我们在这里描述了一种用于非标记重组 LipL32 的替代和简单的纯化方案。重组 LipL32(21-272)在没有 His 标签或任何其他用于促进重组蛋白纯化的标签的情况下在大肠杆菌中表达。重组蛋白以可溶性形式表达,纯化基于离子交换(阴离子和阳离子)和疏水相互作用。最终的纯化从每升诱导培养物中获得 3 毫克可溶性 LipL32(21-272)。针对重组蛋白产生的抗血清可有效检测来自几种钩端螺旋体血清型的细胞提取物中的天然 LipL32。该方案产生的纯化重组 LipL32(21-272)可用于结构、生化和功能研究,并避免了标签的潜在相互作用和干扰,以及当需要无标签 LipL32 时,标签通常耗时且效率低下的切割方法的风险。无标签 LipL32 可能代表生化研究、血清诊断和开发针对钩端螺旋体病的疫苗的替代抗原。